Darren Ashcroft – Research output — Research Explorer The University of Manchester

EmailDarren.Ashcroftmanchester.acuk

10 results

Filter

2021

Examining the burden of potentially hazardous prescribing in English and Welsh prisons: A mixed method study
Abuzour, A., Magola-Makina, E., Dunlop, J., O'Brien, A., Khawagi, W., Ashcroft, D., Brown, P. & Keers, R., 4 Aug 2021, In: Pharmacoepidemiology and Drug Safety. 30, S2, p. 11-11 1 p.
Research output: Contribution to journal › Meeting Abstract › peer-review

Open Access
Measuring mental health prescribing safety indicators in UK primary care
Khawagi, W., Steinke, D., Carr, M., Wright, A., Ashcroft, D., Avery, A. & Keers, R., 24 Aug 2021, In: Pharmacoepidemiology and Drug Safety. 30, S1, p. 117 118 p.
Research output: Contribution to journal › Meeting Abstract › peer-review

Open Access
2020

Spatial Distribution of Deprivation Driven Inequalities in Opioid Prescribing in English Primary Care: A Cross‐sectional Analysis
Nowakowska, M., Zghebi, S. S., Parisi, R., Chen, L.-C., Ashcroft, D. & Kontopantelis, E., 15 Oct 2020, In: Pharmacoepidemiology and Drug Safety. 29, S3, p. 221-221
Research output: Contribution to journal › Meeting Abstract › peer-review
2019
A systematic review of measures using clinical data for assessing the severity of Type 2 diabetes
Zghebi, S. S., Panagioti, M., Rutter, M., Ashcroft, D., Van Marwijk, H., Salisbury, C., Chew-Graham, C., Buchan, I., Qureshi, N., Peek, N., Mallen, C., Mamas, M. & Kontopantelis, E., 5 Mar 2019, In: Diabetic Medicine. 36, S1, p. 169-174 443.
Research output: Contribution to journal › Meeting Abstract › peer-review
Examining medication safety incidents in in‐patient mental health settings: A 7‐year analysis of incidents reported to the National Reporting and Learning System
Alshehri, G., Keers, R. & Ashcroft, D., 2019, In: Pharmacoepidemiology and Drug Safety. p. 5-6 3 p.
Research output: Contribution to journal › Meeting Abstract › peer-review

Open Access
2018

Managing medicines and the role of social networks following hospital discharge: qualitative insights from patients with Chronic Obstructive Pulmonary Disease (COPD)
Schafheutle, E., Fegan, T. & Ashcroft, D., Apr 2018, In: International Journal of Pharmacy Practice . 26, Suppl. 1, p. 10-11 2 p.
Research output: Contribution to journal › Meeting Abstract › peer-review
Severity domains for quantifying the severity of Type 2 diabetes using primary care data and linked hospitalisation records from England
Zghebi, S. S., Rutter, M., Ashcroft, D., Van Marwijk, H., Mallen, C. D., Chew-Graham, C. A., Qureshi, N., Weng, S., Salisbury, C., Reeves, D., Holt, T., Perera, R., Buchanan, I., Peek, N., Mamas, M. A. & Kontopantelis, E., 1 Mar 2018, In: Diabetic Medicine. 35, Suppl. 1, p. 36-205 P519.
Research output: Contribution to journal › Meeting Abstract › peer-review

Open Access
2016

Trends in Incidence and Prevalence of Type 2 Diabetes in the United Kingdom (2004 - 2014) Using the Clinical Practice Research Datalink (CPRD)
Zghebi, S. S., Steinke, D., Carr, M. & Ashcroft, D., 24 Aug 2016, In: Pharmacoepidemiology & Drug Safety. 25, Suppl. 3, p. 75-76
Research output: Contribution to journal › Meeting Abstract › peer-review
2015

Choice of second-line antidiabetic treatment in Type 2 diabetes: influence of patient characteristics
Zghebi, S., Steinke, D. T., Rutter, M. K. & Ashcroft, D. M., Mar 2015, In: Diabetic Medicine. 32, Suppl. 1, p. 205
Research output: Contribution to journal › Meeting Abstract › peer-review
Risk of Major Cardiovascular Events during Second-Line Antidiabetic Treatments: A Population-Based Cohort Study
Zghebi, S. S., Steinke, D. T., Rutter, M. K., Emsley, R. A. & Ashcroft, D. M., 2015, In: Pharmacoepidemiology and Drug Safety. 24, p. 555-556
Research output: Contribution to journal › Meeting Abstract › peer-review